Media Enquiries
Johannesburg, South Africa:
Contact Person: Morne Reinders
Email: morne@articulatepartners.com
Telephone: +27 082 480 4541
Johannesburg, South Africa:
Contact Person: Medisha Deenath
Email: medisha@articulatepartners.com
Telephone: +27 082 480 4541
Download the Crestcare Media Fact Sheet

Crestcare Partners With Bluebird to Advance Infection Control and Antibiotic Stewardship
Johannesburg, South Africa
8 September 2025

Bluebird technology ensures antibiotics are used in the most effective way possible
Supports doctors in prescribing the right antibiotics, in the right amount for the right infection
A cloud-based solution with an intuitive interface and bedside iPad access
Allows doctors and nurses to view comprehensive patient data, track infection trends, and receive automated alerts
Helps prevent the rise of antibiotic-resistant bacteria, which is a growing problem in South Africa
Standardises clinical workflows, enabling hospitals to do more with fewer resources
To be rolled out across all Crestcare Group hospitals, including Crestcare Malmesbury Hospital (Western Cape), Crestcare Zoutpansberg Hospital (Limpopo) and Crestcare St Mary’s Hospital (Mthatha)
08 September 2025. Johannesburg, South Africa - Crestcare Hospital Group (Crestcare) has announced a strategic partnership with Bluebird, a leading infection control and antimicrobial stewardship platform, to enhance patient safety and improve clinical outcomes across its hospital network. This collaboration marks a significant step in Crestcare’s ongoing commitment to delivering world-class healthcare in rural and peri-urban communities through a multidisciplinary, team-based approach.
“Crestcare is deeply invested in ensuring that every patient, regardless of geography, receives the highest standard of care,” says Kit Wostenholm, CEO of Crestcare.
“Partnering with Bluebird allows us to strengthen our infection prevention protocols and empower our clinical teams with real-time data and decision support tools. This is about smarter medicine, safer hospitals, and equitable access to excellence.”
Built from the ground up using the United States’ Centre for Disease Control antimicrobial stewardship guidelines, Bluebird is a mature, cloud-based solution that helps hospitals and doctors identify high-risk patients, reduce infection rates, and optimise antibiotic use. The system standardises clinical workflows, enabling hospitals to do more with fewer resources, a critical advantage in resource-constrained settings.
Bluebird’s intuitive interface and bedside iPad access allow doctors and nurses to view comprehensive patient data, track infection trends, and receive automated alerts. Remote access ensures that multidisciplinary teams - including pharmacists, infection control specialists, and attending physicians - can collaborate seamlessly, even across sites. Minimal IT infrastructure is required, making the system ideal for Crestcare’s decentralised footprint.
Dr Darryl Vine, Medical Director of Bluebird, adds: “Our technology is designed to support doctors in making timely, evidence-based decisions. By automating antibiograms, flagging transmission risks early, and guiding empiric therapy, Bluebird facilitates constructive engagement among care teams. It’s not about dictating treatment, but about empowering doctors with the right information to make faster, more informed decisions. We’re proud to support Crestcare’s mission to extend high-quality care to underserved regions.”
Wostenholm continues: “This means doctors have the option to use technology to ensure antibiotics are used in the most effective way possible. Bluebird looks at the lab results and prescribed treatment and highlights where adjustments might improve outcomes or reduce resistance risk.
“It's a collaborative tool that supports antimicrobial stewardship – using the right antibiotics, in the right amount for the right infection, in support of the clinical judgment of our doctors.”
The partnership will be phased in across Crestcare’s facilities at Crestcare Zoutpansberg Hospital in Limpopo, Crestcare Malmesbury Hospital in the Western Cape and Crestcare St Mary’s in Mthatha in the Eastern Cape, with training and support provided by Intelligent Medical Systems, the company behind Bluebird.
Early implementation sites have already reported improved teamwork, reduced infection rates, and more appropriate antibiotic prescribing.
About Crestcare
Dating back to 2004, Crestcare is a portfolio company of the Summit Private Equity Fund I, which is managed by Summit Africa, a black-owned and managed private equity and impact investment manager focusing on investing in sectors that are pivotal to the economic and social prosperity of South Africa.
The Crestcare Hospital Group currently includes Crestcare Zoutpansberg in Louis Trichardt, Limpopo; Crestcare Surgi Clinic Nelspruit, a specialist hospital serving patients in the broader Mpumalanga, Mozambique and Swaziland regions; Apex Soweto Day Hospital in Soweto, Gauteng; as well as Crestcare Malmesbury in the Western Cape and Crestcare St Mary’s Hospital in Mthatha in the Eastern Cape.
The group aims to have at least 800 beds within the next two years, specifically in peri-urban, rural and township areas.
Contact Crestcare Media Relations
Journalists and other media professionals may use the contact information listed below. For non-media inquiries about Crestcare and its hospitals, please refer to our contacts page. Only media inquiries are handled through the contacts below.
For press related enquiries, please contact:
Johannesburg, South Africa
Contact Person:
Morne Reinders
Email:
Telephone:
Johannesburg, South Africa
Contact Person:
Medisha Deenath
Email:
medisha@articulatepartners.com
Telephone: